Search

everythinglearnresearchcommunity

for

Search:↓

Scalp melanoma, a deadly skin cancer, is often found late due to its hard-to-see location, especially in older men. Early detection, possible treatments, and the role of hairdressers in spotting it early are discussed. More research is needed to improve detection and treatment.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Some aggressive scalp cancers are hard to treat and can be deadly, even when removed with specialized surgery.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Two boys developed a viral skin infection during chemotherapy, which resolved with improved immune function.

Alopecia mucinosa on the face can be linked to mycosis fungoides, a type of lymphoma.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Exosomes can improve skin treatments with fewer side effects.

Melanocyte stem cells hold promise for skin regeneration and treating pigmentation issues.

EGFR is crucial for preventing hair follicle inflammation and hair loss.

Stress can cause hair to turn gray by depleting pigment-producing cells through the release of a stress hormone.

A cancer patient's hair became permanently curly after treatment with nivolumab.

Cancer survivors need better skin care to improve their quality of life.

MicroRNAs are important for skin development and diseases and could be used for treatment and diagnosis.

Understanding molecular processes in skin development is key to creating targeted treatments for skin disorders.

PPAR β/δ is important for skin health and disease treatment, but more research is needed.

The paper concludes that breast cancer treatment involves complex interactions between medical symptoms, patient experiences, and commercial influences, requiring a holistic approach.

Huaier helps hair grow back and repairs tissue after cancer treatment.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Phospholipases help maintain and restore skin and hair health, potentially leading to new treatments for related conditions.

DNA microarrays help study skin diseases and biology, leading to advancements in understanding and treatment.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Bone Morphogenetic Proteins (BMPs) help control skin health, hair growth, and color, and could potentially be used to treat skin and hair disorders.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Androgen receptor inactivation delays skin cancer onset and reduces incidence in mice, with gender differences in susceptibility.

Older people at home often have skin issues, but there's little evidence on how to prevent or treat them effectively.